Canadian medical-technology company Nordion (NDZ +0.8%) gains after its FQ3 swung to a profit on fewer one-time expenses and higher sales. The quarter marks a reversal as sales have slipped in recent quarters, due in part to supply interruptions and the temporary shutdown of a reactor. In its targeted-therapies segment, revenue grew 15%, while gross margins widened to 54.7% from 52.7%.
Check out Seeking Alpha’s new Earnings Center
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (Jul 11, 2014)
at CNBC.com (May 5, 2014)
at CNBC.com (Aug 20, 2013)
at MarketWatch.com (Sep 20, 2012)
at MarketWatch.com (Sep 10, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs